Sign In

Till Erdmann

Managing Director / Founder at Myelo Therapeutics, IDrug, Treamid Therapeutics

Till Erdmann is a seasoned professional with 20 years of experience in the pharmaceutical and diagnostics industry, specializing in areas such as sales, marketing, strategy, fundraising, and business development. He is the founder of IDrug, Myelo Therapeutics, and Treamid Therapeutics. Till Erdmann pursued his education at prestigious institutions such as the Technical University of Berlin, San Francisco State University for an MBA, and Technische Universität Kaiserslautern. His career includes roles like Managing Director and Co-Founder at Myelo Therapeutics GmbH, founder of Treamid Therapeutics and IDrug GmbH, Global Marketing Manager Biomarkers at Thermo Fisher Scientific, Clinical Diagnostics Division, Group Product Manager - Neurology Franchise at Bayer HealthCare, Associate Partner at Type Two Ltd, and Senior Consultant at Gemini Consulting.

Till Erdmann
Add to my network

Location

Berlin Area, Germany